Search PubMed⌕ Search

Biomedical subjects

R J Witorsch

Publications and source records attributed to R J Witorsch.

At least 37 records · Page 2Linked to original sources

Proteolytic degradation and modification of rat prolactin by subcellular fractions of the rat ventral prostate gland.

We previously showed that at pH 7.4, the cytosol and a low speed pellet (3300 X g) of rat ventral prostate degraded rat PRL, whereas a high speed pellet (25,000 X g) was inactive. The current study further explores PRL degradation by ventral prostatic tissue. Enzyme markers indicated that the low speed pellet was mitochondria enriched (cytochrome c oxidase), and the high speed pellet was lysosome enriched (acid phosphatase), although there was considerable cross-contamination between the two fractions. Proteolysis of hormone was examined by incubating 125I-labeled rat iodo-PRL with tissue fractions, followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and radioautography to identify products and quantify the extent of PRL degradation. Acidification of the incubation medium (pH 4-5) to optimize lysosomal protease activities inhibited PRL degradation in cytosol and activated the process in both pellets consistent with the distribution of acid phosphatase. Under acidic incubation conditions, both low and high speed sediments produced the same electrophoretic pattern of PRL degradation, indicating the generation of peptide fragments from the hormone with a molecular mass of approximately 16,000-8,000 daltons. Cytosol (pH 7.4) also produced peptide fragments in this weight range, although at much lower rates and in relatively lower proportions. Peptide fragment formation from PRL by the low speed pellet (pH 7.4) was minimal. On a protein basis, PRL degradation by the high speed sediment (pH 4.5) was 3-10 times that by the low speed sediment (pH 7.4). Enzyme inhibitor analysis indicated differences in each of the cell fractions with regard to the types of proteases involved in PRL degradation. When compared with other tissues of the male rat, ventral prostate was the most active in degrading PRL and generating peptide fragments. In addition, kidney, spleen, and lung were among the more active tissues, whereas liver, was deferens, and dorsolateral prostate were relatively less active in degrading hormone. Our studies indicate that qualitatively different processes degraded PRL in each of the active subcellular fractions and that the generation of peptide fragments from PRL predominates in a lysosome-rich fraction of ventral prostate. The possible significance of subcellular variations in PRL processing and the generation of peptide fragments of the hormone by peripheral tissue are discussed.

Animals↗

Modulation of prolactin binding sites in vitro by membrane fluidizers. I. Effects on adult rat ventral prostatic membranes.

The objective of this study was to determine if aliphatic alcohols, known fluidizers of certain membranes, could increase in vitro the apparent fluidity and prolactin binding capacity of membrane preparations obtained from ventral prostate glands of adult male rats. The degree of fluidization was monitored by a fluorescence polarization method using 1,6-diphenylhexatriene. Membrane preparations were either incubated with varying concentrations of ethanol, 1-propanol or 1-butanol and 125I-oPRL overnight at room temperature or were exposed to the alcohols for 15 min at room temperature and washed prior to the overnight incubation with ligand. Regardless of the conditions of incubation, alcohol exposure produced the same effects, a dose-dependent elevation and then decline in specific prolactin binding. Butanol produced a maximal 37-42% increase in prolactin binding at a concentration of 1.0%, propanol produced a maximal 40-56% increase in prolactin binding at a concentration of 3.8%, and ethanol produced a maximal 54-77% increase in prolactin binding at concentration of 4.8%. Scatchard analysis of the oPRL binding of ventral prostatic membranes indicated that the in vitro treatment of these membrane fluidizers increased the number of oPRL binding sites rather than the apparent affinity constant. The value of the microviscosity parameter decreased by 10-13%, 13-15% and 21-25%, after a 15 min exposure of prostatic membranes to 1.0% butanol, 3.8% propanol and 4.8% ethanol, respectively. These data suggest that in vitro fluidization of prostatic membrane modifies prolactin binding capacity and are consistent with in vivo prostatic prolactin receptor level-membrane fluidity relationships observed in earlier studies.

1-Butanol↗

Proteolytic fragmentation of rat prolactin by the rat ventral prostate gland.

Homogenates of rat ventral prostate diminished the immunoreactivity of rat prolactin (PRL) in a fashion dependent on time and tissue concentration, suggestive of hormone degradation. Direct evidence of PRL proteolysis was demonstrated by subjecting ventral prostate homogenates and cell fractions that were incubated with 125I-labeled rat PRL to SDS-PAGE and radioautography. Heat-labile PRL proteolysis predominated in the crude homogenate, the 3,300g pellet and the 100,000g (100 K g) supernatant of rat ventral prostate. The degradation of PRL by the 100 K g supernatant led to the formation of two stable peptide fragments weighing approximately 16,000 and 12,000 daltons. PRL proteolysis was negligible in 100 K g supernatants of the liver, salivary gland, testis, epididymis, vas deferens, seminal vesicle, and dorsolateral prostates of male rats. On the other hand, 100 K g supernatants of rat spleen, lung, and kidney did degrade rat PRL, although the patterns of peptide fragment formation differed from that of ventral prostate. Enzyme inhibitor analysis suggested that PRL degradation by the 100 K g supernatants of rat ventral prostate was due to sulfhydryl and serine proteases and not due to metalloenzyme or aspartate proteases. The functional significance of PRL fragmentation by rat ventral prostate cytosol remains to be determined.

Animals↗

Indomethacin decreases both luteinizing hormone binding and fluidity of testicular microsomal membranes in rat.

The objective of these studies was to examine the effects of in vivo treatment with indomethacin, a prostaglandin synthesis inhibitor, on luteinizing hormone receptors and fluidity in microsomal membrane preparations of rat testis. Adult male rats were treated with vehicle or either of two doses of indomethacin (3.8 micrograms/g body weight or 7.5 micrograms/g body weight) every 8 h for 1, 2 and 3 days. Indomethacin treatment decreased human luteinizing hormone (hLH) binding in rat testis in a time-dependent fashion. The lower dose of indomethacin decreased hLH binding by 19%, 35% and 50%, respectively, after 1, 2 and 3 days of treatment. The higher dose of indomethacin decreased hLH binding at these respective times by 21%, 44% and 56%. Scatchard analysis of the hLH binding of testicular membrane preparations indicated that indomethacin treatment decreased the number of hLH binding sites rather than the apparent affinity constant. Testicular membrane fluidity was estimated by a fluorescence polarization technique. The effects of indomethacin on apparent fluidity of microsomal membrane paralleled that of LH binding. The values of apparent microviscosity, inversely related to the fluidity, also increased in a time-dependent fashion. These simultaneous effects of indomethacin on testicular LH binding and fluidity suggest that these phenomena are interrelated and that prostaglandins are involved in the maintenance of LH receptors in vivo.

Animals↗

Regional variations in the testicular dependence of prolactin binding and its possible relationship to castration-induced involution in rat prostate gland.

Prolactin binding sites of ventral, lateral, and dorsal lobes of rat prostate were examined immunohistochemically 1, 2, 4, and 8 days after castration or sham operation. In sham-operated rats each lobe exhibited a distinct pattern of intracellular and intraluminal prolactin binding. A loss in prolactin binding from epithelial cells of ventral prostate, which was visualized postcastration, was quantitated with the aid of an image analyzer and then statistically evaluated. The proportion of ventral prostate epithelial cells devoid of prolactin binding increased from approximately 13% in sham-operated rats to approximately 29% 1 day after castration, and reached a peak level of about 71% 4 days postcastration. No loss of prolactin binding was evident in either lateral or dorsal prostate up to 8 days postcastration. Direct measurement of epithelial cell heights and subsequent statistical evaluation revealed similar regional differences in the rates and extent of prostate involution. Eight days after castration ventral prostate epithelial cell heights decreased by 56% whereas lateral and dorsal lobe epithelial cells heights decreased about 25% and 14%, respectively. The apparent relationship between testicular dependence of prostatic prolactin binding and castration-induced prostatic involution are discussed in terms of possible regional variations in the prolactin-androgen interplay in prostate.

Animals↗

Evaluation of immunoperoxidase-stained tissue sections with an electrophoresis densitometer.

The application of the Phoroscope electrophoresis densitometer for the objective evaluation of immunoperoxidase-stained tissue sections at the light microscope level is described. The instrument directs a beam of light through the specimen (Kodachrome photomicrograph slides) and projects an absorbance pattern (as peaks and valleys) on an oscilloscope screen. The height of a peak is proportional to the optical density of a stained area, while the width of the peak is proportional to the diameter of an area. The utility of the densitometer was tested in sections of rat pituitary gland immunostained with NIAMDD antiserum against rat prolactin to reveal prolactin cells and sections of rat ventral prostate pretreated with NIAMDD rat prolactin and then immunostained to reveal Golgi region-localized prolactin binding sites in epithelial cells. The densitometer quantitated (by relative absorbance) the changes in immunostaining in serial sections of rat pituitary gland reacted with different dilutions of prolactin antiserum and in serial sections of rat ventral prostate pretreated with different concentrations of rat prolactin. In addition, the densitometric pattern provided information regarding the frequency and pattern of immunostaining within a particular microscopic field. Potential uses of an electrophoresis densitometer for the quantitation and standardization of immunohistochemistry are discussed.

Animals↗

The application of immunoperoxidase methodology for the visualization of prolactin binding sites in human prostate tissue.

In previous studies the immunoperoxidase method was used to detect intracellular prolactin binding sites in epithelial cells of normal and neoplastic rat prostate. As an extension of this work, the same approach was used to test for and to localize prolactin binding sites in autopsy and biopsy specimens of formalin fixed, paraffin embedded human prostate. Rehydrated tissue sections were exposed to varying concentrations of human placental lactogen or human prolactin and then to human placental lactogen or human prolactin antisera. The loci of hormone binding were visualized by an immunoperoxidase staining sequence. Hormone pretreatment produced immunospecific, dose related staining inside epithelial cells of normal, hyperplastic, and neoplastic human prostate indicative of intracellular prolactin binding. The patterns of intracellular hormone binding in human prostate were similar to those seen previously in rat prostate tissue. The possible involvement of prolactin in prostatic cancer and the potential diagnostic value of the immunoperoxidase approach to hormone binding are discussed.

Binding Sites↗

Immunohistochemical localization of prolactin-binding sites in R3327 rat prostatic cancer cells.

Light microscope immunohistochemistry was used to test for and to localize prolactin-binding sites in the transplantable R3327 rat prostatic carcinoma. Fixed tissue sections of the tumor were first incubated with vehicle or varying concentrations of highly purified NIAMDD rat prolactin and then exposed to an immunoperoxidase staining sequence. Prolactin produced dose-related, immunospecific, staining in the cytoplasm of some neoplastic cells, indicative of intracellular prolactin-binding sites (IPBS). While cells with IPBS have been demonstrated in both differentiated and undifferentiated regions of this cancer, a role for prolactin in prostatic neoplasia, be it stimulatory or inhibitory, remains to be elucidated.

Animals↗

Collagen synthesis in capsules surrounding dimethylbenzanthracene-induced rat breast tumors and the effect of pretreatment with beta-aminopropionitrile.

Collagen synthesis is increased over three-fold in capsules surrounding dimethylbenzanthracene-induced rat breast tumors compared to the tumor parenchyma and over six-fold compared to normal breast connective tissue. Increased collagen synthesis is independent of the rate of tumor growth and final tumor size. Pretreatment of animals with beta-aminopropionitrile to inhibit collagen cross-linking caused an 82% decrease in tumor formation and a significant reduction in tumor volume (approximately 0.4 cu cm) compared to controls (approximately 10 cu cm). The four small tumors that did develop in the lathyritic animals had increased collagen synthesis in the interior tumor stroma and reduced collagen synthesis in the tumor capsule. These findings suggest that the collagenous capsule surrounding dimethylbenzanthracene tumors functions as a physical barrier to protect the tumor from the immune system of the host. The apparent antitumor effects of beta-aminopropionitrile may be due to immunopotentiation and/or cytotoxic actions of the drug.

9,10-Dimethyl-1,2-benzanthracene↗

Freezing and storage of breast cancer tissue for estrogen receptor protein assay: a convenient method.

Sixteen patients underwent biopsy of primary or metastatic breast cancer and had equal portions of the tumors rapidly frozen by either the use of liquid nitrogen or the fluorinated hydrocarbon spray, Cryokwik. The estrogen receptor protein (ERP) assay was then performed on both specimens, utilizing the surcose gradient density method. In general, both methods of freezing gave similar results. Three patients had ERP measured after approximately three to four months of storage at -70 C. After a minimum of 14 weeks' storage, there was no statistically significant loss of activity by either method of preparation. The Cryokwik preparation method makes the accurate measurement of ERP possible for all community hospitals. The tissue may be prepared and stored until a convenient time for transportation to the appropriate laboratory.

Breast Neoplasms↗

Detection of endogenous immunoreactive prolactin in rat mammary epithelial cells during lactation.

The question of whether endogenous prolactin might be detectable in normally lactating rat mammary glands (LMG) was examined by light microscopic immunohistochemistry. In an initial study, sections of LMG were incubated sequentially with I) rabbit anti-rat prolactin (APRL); II) anti-rabbit gamma globulin: peroxidase conjugate (ARgammaG-per), prepared from goat anti-rabbit gamma globulin and horseradish peroxidase, and III) 3,3'-diaminobenzidine mixed with H2O2(DAB). Use of this three-step procedure led to staining of stromal, parenchymal and intraluminal elements. However, control procedures which ommitted step I produced similar staining, caused by direct binding of the ARgammaG-per to endogenous tissue components (possibly rat immunoglobulins). This precluded detection of indirect, APRL-linked, binding of ARgammaG-per. In subsequent experiments, direct binding of ARgammaG-per was prevented by preincubating LMG sections with goat anti-monkey gamma globulin (AMgammaG), following which, the three-step reaction sequence (APRL, ARgammaG-per and DAB) led to APRL-dependent staining, both within the alveolar lumina and in the apices of epithelial cells. This staining, presumably of endogenous prolactin, appeared to be specific, since it did not occur when absorbed APRL (APRL admixed with highly purified rat prolactin) was substituted for APRL in step I of the reaction sequence. In contrast, when an incubation with purified rat prolactin was interposed between the AMgammaG pretreatment and the three-step reaction sequence, staining of epithelial elements was intensified, indicating that these cells had contained unoccupied prolactin-binding sites. The apparent presence of both prolactin-binding sites and endogenous immunoreactive prolactin in LMG alveolar cells strongly suggests that this protein hormone can enter these target cells under physiological conditions.

Animals↗

Comparison of effects of prolactin and growth hormone on adrenal 5alpha-reductase in hypophysectomized rats.

Adrenal 5alpha-reductase activity was measured in female rats 0, 2, 5, and 6 days after hypophysectomy. Enzyme activity increased progressively exhibing a 35-fold elevation at 6 days. The effects of high (250 mug/100 g of body wt), intermediate (25 mug/100 g of body wt), and low (2.5 mug/100 of body wt) daily doses of bovine prolactin and bovine growth hormone were compared at 2 and 5 days posthypophysectomy. At 2 days, enzyme activity was partially inhibited by the high and intermediate doses of prolactin and not affected by growth hormone. At 5 days all doses of prolactin were inhibitory, whereas enzyme activity was suppressed only by the high dose of growth hormone. With a given dose of hormone, the amount of suppression of enzyme activity is greater at 5 days than at 2 days posthypophysectomy. In 5-day hypophysectomized rats the inhibitory effects of prolactin and growth hormone were additive. It is concluded that: (i) hormonal sensitivity and responsiveness of the adrenal reductase pathway increases with duration of pituitary ablation; (ii) the reductive pathway is more sensitive to the effects of prolactin than growth hormone; and (iii) the effects of growth hormone and prolactin on reductase activity are mediated via different mechanisms, as suggested by the additive effects of individual hormones.

Adrenal Glands↗